TESTBANK Understanding Pharmacology: Essentials for Medication Safety 3rd Edition

Test Bank for Understanding Pharmacology Essentials for Medication Safety,
3rd Edition by M. Linda Workman & LaCharity

,Chapter9b01:9bDrug9bRegulation,9bActions,9band9bResponses
Workman9b&9bLaCharity:9bUnderstanding9bPharmacology:9bEssentials9bfor9bMedication9bSafety,9b3rd9bEdi
tion

MULTIPLE9bCHOICE9bBASIC9 b CO

NCEPTS

1. Which9bhealth9bcare9bprofessional9bhas9bthe9bmajor9bresponsibility9bfor9bdispensing9bpresc
ribed9 b drugs9bunder9bthe9bdirection9bof9ba9bpharmacist?
a. Physician
b Nurse9bpractitioner
.
c. Licensed9bnurse
d Pharmacy9btechnicia
. n


ANS:9b9 b D
The9bphysician9band9bnurse9bpractitioner9bhave9bthe9bmajor9bresponsibility9bfor9bprescribing9bdrugs,9bnot
9 b dispensing9bthem.9bThe9blicensed9bnurse9bhas9bthe9bprimary9bresponsibility9bfor9badministering9bdrug

s,9 b although9bunder9bsome9bcircumstances9ba9blicensed9bnurse9bmay9bdispense9bprescribed9bdrugs9bbut9bt
his9bis9bnot9 b his9bor9bher9bmajor9bresponsibility9bin9bdrug9btherapy.9bThe9bpharmacy9btechnician9bhas9bt
he9bmajor9 b responsibility9bof9bdispensing9bprescribed9bdrugs9bunder9bthe9bdirection9bof9ba9blicensed9bpha
rmacist.

DIF: Cognitive9bLevel:9bRemembering REF: p.9b3

2. Which9bterm9bdescribes9bthe9beffect9bof9ba9bdrug9bthat9bimproves9bbody9bfunction?
a. Side9beffect
b Intended9bactio
. n
c. Adverse9breaction
d Idiosyncratic9bresponse
.


ANS:9b9 b B
The9bpurpose9bof9bdrug9btherapy9bis9bto9btake9ba9bdrug9bto9bprevent,9breduce,9bor9bcorrect9ba9bhealth9bproblem.
9bThis

response9bis9bany9bdrug’s9bintended9baction9balso9bknown9bas9ba9btherapeutic9bresponse.

DIF: Cognitive9bLevel:9bRemembering REF: p.9b3

3. Which9btype9bof9bdrug9bname9bis9b“owned”9bby9bthe9bcompany9bthat9bmanufactures9bit?
a. Generic9bname
b Chemical9bname

,.
c. Category9bname
d Trade9bnam
. e


ANS:9b9 b D
The9bchemical9bname9bis9ba9bdrug’s9bexact9bchemical9bcomposition.9bThe9bgeneric9bname9bis9bthe9bname9ba
ssigned9bto9 b the9bdrug9bby9bthe9bU.S.9bAdopted9bNames9bCouncil9band9bis9bnot9bowned9bby9banyone.9bThe9bc
ategory9bname9brefers9 b to9bthe9btype9bof9bdrug9b(what9bit9bdoes9bor9bwhat9bit9bis9bused9bfor)9band9bis9bnot9ban
9bactual9bdrug9bname.9bThe9btrade9 b name9b(brand9bname)9bis9bthe9bname9bprovided9band9bowned9bby9ba9bs

pecific9bdrug’s9bmanufacturer.

DIF: Cognitive9bLevel:9bRemembering REF: p.9b4

4. Which9bdrug9bor9bdrug9bclass9bis9ba9b“high9balert”9b
a. Penicillin
drug?
b Insulin
.
c. NSAIDs
d Calcium
.


ANS:9b9 b B
A9bhigh9balert9bdrug9bis9bone9bin9bwhich9bharm9bis9blikely9bto9bresult9bif9bgiven9bat9bthe9bwrong9bdose,9bto9bth
e9bwrong9 b patient,9bor9bnot9bgiven9bto9bthe9bcorrect9bpatient.9bDrugs9bclassified9bas9bhigh9balert9bdrugs9bincl
ude9bpotassium,9 b narcotics9b(opioids),9binsulin,9bcancer9bchemotherapy9bdrugs,9band9bheparin9b(or9bany9
bdrug9bthat9bstrongly9 b affects9bblood9bclotting).9bPenicillin,9bNSAIDs,9band9bcalcium9bare9bnot9bconsidere

d9bhigh9balert9bdrugs.

DIF: Cognitive9bLevel:9bRemembering REF: p.9b4

5. What9bis9bthe9bterm9bfor9ba9bdrug9bthat9bhas9bthe9bsame9baction9bas9ba9bnaturally9boccurri
ng9bbody9 b hormone9bor9benzyme?
a. Agonist
b Blocking9bagent
.
c. Chemical
d Duplicator
.


ANS:9b9 b A
A9bdrug9bagonist9bis9ban9bextrinsic9bdrug9bthat9bactivates9bthe9breceptor9bsites9bof9ba9bcell9band9bmimics9bthe9bact
ions9bof9 b naturally9boccurring9bbody9bsubstances9b(intrinsic9bdrugs).9bA9bblocking9bagent9bis9ba9bdrug

, antagonist.9bA9bchemical9bwould9bnot9bnecessarily9bbe9ba9bdrug9bat9ball.9bA9bduplicator9bis9bnot9ba9bpharmacolo

gic9bterm.9 b DIF: Cognitive9bLevel:9bRemembering REF: pp.9b6-

7

6. Which9bterm9bdescribes9bhow9bthe9bbody9baffects9bdrug9bactivity?
a. Drug9bpotency
b Pharmacodynamics
.
c. Therapeutic9beffect
d Pharmacokinetics
.


ANS:9b9 b D
The9bterm9bpharmacokinetics9brefers9bto9bdrug9bmetabolism9band9bhow9bthe9bbody9bchanges9ba9bdrug.9 b P
harmacodynamics9brefers9bto9bhow9ba9bdrug9bworks9bto9bchange9bbody9bfunction.9bDrug9bpotency9brefers9bt
o9bhow9 b strongly9bor9bto9bwhat9bdegree9ba9bdrug9bexerts9bits9beffects.9bThe9btherapeutic9beffect9bis9bcloser9b
to9 b pharmacodynamics,9bmeaning9bhow9ba9bdrug9bworks9bto9bchange9bbody9bfunction.

DIF: Cognitive9bLevel:9bRemembering REF: p.9b10

7. In9bthe9bUnited9bStates,9bwhich9bgroup9bis9bresponsible9bfor9benforcing9bestablished9bstandar
ds9bfor9 b drug9bmanufacturing?
a. U.S.9bPharmacopeia
b National9bInstitutes9bof9bHealth
.
c. Food9band9bDrug9bAdministratio
d Association
n 9bof9bPharmaceutical9bManufacturers

.


ANS:9b9 b C
The9b standards9bfor9bdrug9bmanufacture9b are9b established9bby9b the9b U.S.9bPharmacopeia.9bThese9b stand
ards9b are9 b enforced9 b by9 b the9 b Food9 b and9 b Drug9 b Administration.9 b Neither9 b the9 b National9 b Institute
s9 b of9 b Health9 b nor9 b the9 b Association9bof9bPharmaceutical9bManufacturers9bhas9bany9bauthority9bto9benfo
rce9bdrug9bstandards.

DIF:9b9b9b9 b Cognitive9bLevel:9bRemembering9b9b9b9b9b9b9b9b9 b REF:9b9b9 b p.9b5

8. Which9bfactor9bis9ba9bmajor9bdisadvantage9bof9bthe9btransdermal9bdrug9bdelivery9broute?
a. Only9ba9bprescriber9bcan9badminister9bdrugs9bby9bthe9btransdermal9brout
b e.
Transdermal 9bdrugs9bmust9bbe9bsterile9brather9bthan9bclean.

.
c. First9bpass9bdrug9bloss9bby9bthis9broute9bis9bthe9bmost9bextensive.
d Drug9babsorption9bis9bdependent9bon9badequate9bcirculati
on.